Hodgkin Lymphoma Current Events | Hodgkin Lymphoma News | 7
|
| Page
7 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows. view more (2009-08-05)
Improved diagnostic technology for Crohn's disease
The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows. view more (2006-01-31)
Research suggests new cellular targets for HIV drug development
Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions. view more (2009-05-28)
Studying cancer in pet dogs to find new treatments for human patients
A team of scientists at the National Cancer Institute (NCI) in Bethesda, USA, says that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human cancers. view more (2009-10-13)
UBC research finds molecular
University of British Columbia researchers have discovered a "molecular key" that could help increase the success of blood stem cell transplants, a procedure currently used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia. view more (2009-04-23)
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
EUROCARE 3 - new European cancer survival figures
Survival figures for cancer in Europe show large differences between countries - more than can reasonably be accounted for by artefact, bias or chance, according to the authors of the EUROCARE-3 study "Cancer survival in Europe at the end of the 20th century". view more (2003-09-22)
Volcanoes, asteroids and mass extinctions
Neither massive volcanic eruptions nor extraterrestrial impacts are sufficiently powerful on their own to cause mass extinctions of life on Earth, research by University of Leicester geologists suggests. Instead, both events coincidentally occurring together may be required to cause the worst mass extinctions. In the last 300 million years, life... view more... (2004-05-17)
New treatment approach promising for lymphoma patients in the developing world
Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. view more (2008-07-07)
Nature press release for 19 July issue
[412352] LIFELINES: TRIPLE CHECK (pp352-355; N&V) There are currently two well established main checkpoints in cell division. In this week’s Nature, researchers report a new type of checkpoint in yeast. This finding could lead to a better understanding of how cells form different tissues. For cell division to work, each daughter cell must... view more... (2001-07-19)
Severe Sepsis Causes Almost 10% Of Cancer Deaths
Severe sepsis, is a costly complication in hospitalized cancer patients causing around one in ten cancer deaths each year in the USA, according to an article published today in Critical Care. The excessive response to infection in patients with severe sepsis injures critical organs such as the lungs and kidneys. Dr Mark Williams and his colleagues... view more... (2004-07-01)
Survivors of childhood leukemia, brain tumors more at risk for strokes later in life
Children who are successfully treated for brain tumors or leukemia are more likely to have strokes later in life, according to new research from UT Southwestern Medical Center. view more (2006-11-20)
Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
Cancer patients who have been successfully treated for their disease face the prospect of its return if stored ovarian (or testicular) tissue is transplanted back into their bodies without adequate checks, according to researchers at two university hospitals in Israel. view more (2008-04-22)
New test proves effective in more cancers
Avantogen Limited (ACU:ASX) today announced that cancer researchers at Perth's Telethon Institute for Child Health Research (TICHR) and Avantogen Limited have achieved an important milestone towards more individually targeted and effective treatments for cancer patients. view more (2005-10-07)
Activating protein enhances average lifespan, limits age-related disease in mice
Metabolism researchers at Washington University School of Medicine in St. Louis have found that although it does not extend maximum lifespan in mice, activating a protein in muscle tissue increases average lifespan and prevents some age-related diseases. view more (2007-12-05)
Glue inside the cell: Ubiquitin builds up an immune response
Ubiquitin is a small protein, which can be attached to other cellular proteins, a process known as ubiquitination. Discoveries in the 1980 th on a key function of ubiquitination in the regulation of protein degradation where awarded with the Nobel Prize for chemistry in 2004. view more (2007-10-22)
Stopping autoimmunity before it strikes
Current research describes a new method to track the development of autoimmune diseases before the onset of symptoms. The related report by Zangani et al, "Tracking early autoimmune disease by bioluminescent imaging of NF-κB activation reveals pathology in multiple organ systems," appears in the April 2009 issue of The American... view more... (2009-03-25)
New findings show Enbrel significantly reduced levels of C-reactive protein
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. view more (2008-02-04)
New test piloted for childhood leukaemia
A new screening test to be piloted in Bristol could help to revolutionise the way children with leukaemia are treated by enabling doctors to fine tune treatment to the needs of each individual patient. Experts from five centres - Bristol, Glasgow, Leeds, London and Sheffield - will pilot the test for the most common form of the childhood leukaemia... view more... (2002-08-05)
Cancer mortality rates experience steady decline
The number of cancer deaths has declined steadily in the last three decades. Although younger people have experienced the steepest declines, all age groups have shown some improvement. view more (2009-08-13)
|
|
| Page
7 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
|
